Edward Paul Walker

Affiliations

  • at Neuehealth Inc. (NEUE), 2024-10-03
  • at Mbx Biosciences Inc. (MBX), 2024-09-18
  • at Allakos Inc. (ALLK), 2024-05-30
  • at Korro Bio Inc. (KRRO), 2024-04-24
  • Large Shareholder at Savara Inc (SVRA), 2023-07-19
  • Large Shareholder at Mirum Pharmaceuticals Inc. (MIRM), 2023-06-15
  • Large Shareholder at Akouos Inc. (AKUS), 2022-12-02
  • Large Shareholder at Genocea Biosciences Inc. (GNCA), 2022-05-26
  • Large Shareholder at Trevi Therapeutics Inc. (TRVI), 2022-04-13
  • Large Shareholder at Metacrine Inc. (MTCR), 2021-12-27
  • Director at Trillium Therapeutics Inc. (TRIL), 2021-11-19
  • Large Shareholder at Monte Rosa Therapeutics Inc. (GLUE), 2021-06-30
  • Large Shareholder at Marker Therapeutics Inc. (MRKR), 2021-03-18
  • Other at Regulus Therapeutics Inc. (RGLS), 2021-03-17
  • Director at Tracon Pharmaceuticals Inc. (TCON), 2020-06-16
  • Large Shareholder at Black Diamond Therapeutics Inc. (BDTX), 2020-01-30
  • Director at Tesaro Inc. (TSRO), 2014-06-04
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MBX $16.00 500,000 3,614,486 2024-09-16 Filing
KRRO $56.00 17,857 1,090,793 2024-04-22 Filing
SVRA $3.00 333,333 Large Shareholder 24,471,264 2023-07-17 Filing
ALLK $5.02 3,386,400 Director 3,386,400 2022-09-21 Filing
ALLK $5.02 597,600 Director 2,760,860 2022-09-21 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GNCA $0.08 4,445,093 Large Shareholder 0 2022-05-25 Filing
GNCA $0.07 5,931,843 Large Shareholder 4,445,093 2022-05-24 Filing
MTCR $0.91 170,932 Large Shareholder 2,563,257 2021-12-22 Filing
MTCR $1.00 288,768 Large Shareholder 2,734,189 2021-12-22 Filing
MTCR $1.32 37,570 Large Shareholder 3,022,957 2021-12-10 Filing